1,3-N-Dipropyl-7-Propargylxanthine

Also written (correctly) as 1,3-di-n-propyl-7-propargylxanthine. A synthetic caffeine analog that is reportedly 100 times more potent than caffeine at both A1 and A2 adensosine receptors.  It has not, however, been tested in humans.